|
![]() |
|||
|
||||
OverviewPsychedelics in Psychiatry, Volume 181, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Chapters in this new volume include History of psychedelic drug science and molecular pharmacology, Pharmacological mechanisms and neuroplastic potential of non-psychedelic agents, Anti-inflammatory activity, Translational approaches for investigating the effects of psychedelics on cognitive and affective behaviors in rodents, Clinical pharmacology, Human neuroimaging fMRI, and more. Other chapters in this new release include Effects of psychedelics on human oscillatory brain activity, Molecular neuroimaging of psychedelic drug effects, Neurobiology of sub-psychedelic doses, Depression and related disorders, Addictions, Trauma disorders, Neurological disorders, and Challenges to the developing field of psychedelic medicine - political and ethical considerations and commercialization of therapy. Full Product DetailsAuthor: David J. Nutt (Psychopharmacology Unit, University of Bristol, UK<br>Professor of Psychopharmacology) , Hannah ThurgurPublisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Weight: 0.450kg ISBN: 9780443343858ISBN 10: 0443343853 Pages: 442 Publication Date: 27 June 2025 Audience: Professional and scholarly , College/higher education , Professional & Vocational , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsSection 1 1. History of psychedelic drug science and molecular pharmacology 2. Pharmacological mechanisms and neuroplastic potential of non-psychedelic agents 3. Anti-inflammatory activity 4. Translational approaches for investigating the effects of psychedelics on cognitive and affective behaviors in rodents 5. Clinical pharmacology 6. Human neuroimaging fMRI 7. Effects of psychedelics on human oscillatory brain activity 8. Molecular neuroimaging of psychedelic drug effects 9. Neurobiology of sub-psychedelic doses Section 2 10. Depression and related disorders 11. Addictions 12. Trauma disorders 13. Neurological disorders Section 3 14. Challenges to the developing field of psychedelic medicine - political and ethical considerations and commercialization of therapyReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |